Chanticleer
Blue chip Cochlear lays down blue-chip result, gets more expensive
It is rare to see all of Cochlear’s divisions and territories pumping at the one time, as happened in the year to June 30.
You can see why investors love Cochlear. It’s globally relevant, important, sells an essential service, is in a net cash position and has once again knocked it out of the park.
Loading...
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Healthcare & fitness
Fetching latest articles